Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Published Only

Poor Glycaemic Control—Identifying Variables Associated with Therapeutic Inertia and Lack of Therapeutic Adherence

  1. ANA CEBRIAN,
  2. FERNANDO ALVAREZ GUISASOLA,
  3. FRANCESC XAVIER COS,
  4. MANUEL RUIZ QUINTERO,
  5. JOSE MANUEL MILLARUELO,
  6. DOMINGO OROZCO BELTRAN,
  7. SEMFYC DIABETES THE SPANISH SOCIETY OF FAMILY MEDICINE DIABETES GROUP
  1. Cartagena, Spain, León, Spain, Barcelona, Spain, Alicante, Spain, Zaragoza, Spain
Diabetes 2018 Jul; 67(Supplement 1): -. https://doi.org/10.2337/db18-2407-PUB
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Two main causes of poor glycaemic control has been describe in diabetic patients: lack of patient adherence to antidiabetic drugs and lack of treatment intensification by the physician.

Aim: To analyse variables associated to therapeutic inertia(TI) or lack of adherence in diabetic patients with poor glycaemic control in Spanish primary care.

Methods: Observational cross sectional nationwide study. 48 primary care physicians (PCP) from the Spanish working group on diabetes mellitus from the Sociedad Española de Medicina de Familia. 4patients randomly selected from each surgery. Individualized glycemic targets were calculated according to the algorithm from Cahn A et al (Diabetes Care 2016). TI was defined as a patient with good adherence, according to PCP opinion, but with poor individualized glycaemic control (GC).

Results: 60.5% of patients had good GC (group A), and 39.5% had poor control, 22.1% due to TI (group B) and 17.4% due to poor therapeutic adherence (PTA) (Group C). All three group of patients differ according to the following variables, respectively: age (69.5 vs. 70.5 vs. 63.8 years; p=0.000); HbA1c (6.27 vs. 7.75 vs. 8.46%; p=0.000); number of antidiabetic drugs (1.3 vs. 2.0 vs. 2,1; p=0.000); prevalence of osteoarthritis (50.5 vs. 44.4 vs. 29,7%; p=0.013); risk of hypoglycaemia (66.7 vs. 64.3 vs. 37.5%; p=0.000); physicians time (years) in the practice (12.5 vs. 15.3 vs. 11.5 years; p=0.000). No differences were found in number of comorbidities, gender, cognitive impairment, micro or macro vascular complications, cancer, thyroid dysfunction, dyslipidemia, arterial hypertension, COPD, anxiety, or depression.

Conclusions: 39.5% of diabetic patients have poor glycaemic control according to individualized targets; 22.1% due to TI and 17.4% due to poor therapeutic adherence. Patients with TI compared to patients with PTA were older, with lower A1c, higher risk of hypos, higher prevalence of ostheoartritis and with a PCP with more years in the practice.

Disclosure A. Cebrian: None. F. Alvarez Guisasola: None. F. Cos: Speaker's Bureau; Self; Novartis Pharmaceuticals Corporation. Advisory Panel; Self; Novo Nordisk Inc.. Speaker's Bureau; Self; Boehringer Ingelheim GmbH, Novo Nordisk Inc.. Advisory Panel; Self; Eli Lilly and Company. Speaker's Bureau; Self; Eli Lilly and Company. Advisory Panel; Self; Sanofi Pasteur. Speaker's Bureau; Self; Sanofi Pasteur. Advisory Panel; Self; Sanofi-Aventis. Speaker's Bureau; Self; Sanofi-Aventis. Research Support; Self; Eli Lilly and Company. M. Ruiz Quintero: None. J. Millaruelo: None. D. Orozco Beltran: None.

  • © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 67 (Supplement 1)

In this Issue

July 2018, 67(Supplement 1)
  • Table of Contents
  • Index by Author
  • Abstract PDFs
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Poor Glycaemic Control—Identifying Variables Associated with Therapeutic Inertia and Lack of Therapeutic Adherence
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Poor Glycaemic Control—Identifying Variables Associated with Therapeutic Inertia and Lack of Therapeutic Adherence
ANA CEBRIAN, FERNANDO ALVAREZ GUISASOLA, FRANCESC XAVIER COS, MANUEL RUIZ QUINTERO, JOSE MANUEL MILLARUELO, DOMINGO OROZCO BELTRAN, SEMFYC DIABETES THE SPANISH SOCIETY OF FAMILY MEDICINE DIABETES GROUP
Diabetes Jul 2018, 67 (Supplement 1) 2407-PUB; DOI: 10.2337/db18-2407-PUB

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Poor Glycaemic Control—Identifying Variables Associated with Therapeutic Inertia and Lack of Therapeutic Adherence
ANA CEBRIAN, FERNANDO ALVAREZ GUISASOLA, FRANCESC XAVIER COS, MANUEL RUIZ QUINTERO, JOSE MANUEL MILLARUELO, DOMINGO OROZCO BELTRAN, SEMFYC DIABETES THE SPANISH SOCIETY OF FAMILY MEDICINE DIABETES GROUP
Diabetes Jul 2018, 67 (Supplement 1) 2407-PUB; DOI: 10.2337/db18-2407-PUB
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

Published Only

  • Neudesin, a Novel Regulator of Energy Metabolism in Obesity and Type 2 Diabetes Mellitus—The Effect of Acute Fasting and Endoscopic Duodenal-Jejunal Bypass Liner Implantation
  • Association between IGF1/IGFBP3 with Lipid Metabolism and Chronic Low-Grade Inflammation and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects
  • A Novel Role of Growth Differentiation Factor 3 for the Regulation of Muscle Metabolism
Show more Published Only

Epidemiology/Genetics

  • Evaluation of 24-Hour Blood Pressure and Arrhythmias through Simultaneous Ambulatory Blood Pressure Monitoring and Holter Monitoring in Type 2 Diabetes Mellitus Patients with Hypertension
  • Association between Serum Amylase Level and Incidence of Type 2 Diabetes
  • Saccharomyces Boulardii Attenuates Autonomic Cardiovascular Dysfunction and Modulates Inflammatory Cytokines in Diabetic Mice
Show more Epidemiology/Genetics

Epidemiology–Other

  • Identification of Patient Profiles with Better Glycemic Outcomes Using Machine Learning—Results from the International Diabetes Management Practices Study (IDMPS)
  • Assessment of Body Shape Index for Predicting Type 2 Diabetes in Korean Elderly Population—The Chungju Metabolic Disease Cohort (CMC) Study
  • Factors Associated with Achievement of Glycemic Goal in Africa—Results from the International Diabetes Management Practices Study (IDMPS)
Show more Epidemiology–Other

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.